• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人溶酶体酶α-L-艾杜糖醛酸酶在中国仓鼠卵巢细胞中的过表达。

Overexpression of the human lysosomal enzyme alpha-L-iduronidase in Chinese hamster ovary cells.

作者信息

Kakkis E D, Matynia A, Jonas A J, Neufeld E F

机构信息

Department of Pediatrics, Harbor-UCLA Medical Center, Torrance 90502.

出版信息

Protein Expr Purif. 1994 Jun;5(3):225-32. doi: 10.1006/prep.1994.1035.

DOI:10.1006/prep.1994.1035
PMID:7950365
Abstract

We developed a Chinese hamster ovary (CHO) cell line that produces and secretes large quantities of recombinant human alpha-L-iduronidase, the lysosomal hydrolase deficient in mucopolysaccharidosis I (Hurler, Hurler-Scheie, and Scheie syndromes). The alpha-L-iduronidase cDNA was introduced into a vector containing the cytomegalovirus immediate early gene promoter/enhancer, a murine immunoglobulin C alpha region intron, and the bovine growth hormone polyadenylation signal. Following cotransfection with a plasmid containing the neomycin resistance gene, stably transfected lines were selected with G-418. The highest expressing CHO cell line contained 1400-6000 units of alpha-L-iduronidase per milligram of protein, or 0.6-2.4% of total cell protein. Secreted alpha-L-iduronidase was 3000- to 7000 fold increased, with about 5000 units accumulating in 24 h per 10(7) cells. The activity and distribution of five other lysosomal glycosidases were not significantly affected. Metabolic labeling showed that half of the newly synthesized alpha-L-iduronidase was secreted, but generally less was recovered due to its instability in the medium. It was post-translationally processed as previously shown for alpha-L-iduronidase of human fibroblasts. Recombinant alpha-L-iduronidase was efficiently endocytosed by Hurler fibroblasts utilizing a mannose 6-phosphate-dependent mechanism (half maximal uptake at 0.7 nM) and was "corrective" for abnormal glycosaminoglycan accumulation (half-maximal correction at 0.7 pM). The half-life of the recombinant enzyme was 5 days following uptake into Hurler fibroblasts. Production in a 5-liter microcarrier culture system permitted the collection of 15 mg or more per day.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们构建了一种中国仓鼠卵巢(CHO)细胞系,该细胞系可产生并分泌大量重组人α-L-艾杜糖醛酸酶,这是一种溶酶体水解酶,在黏多糖贮积症I型(胡勒氏综合征、胡勒-谢伊氏综合征和谢伊氏综合征)中缺乏。将α-L-艾杜糖醛酸酶的互补DNA(cDNA)导入一个载体,该载体包含巨细胞病毒立即早期基因启动子/增强子、小鼠免疫球蛋白Cα区域内含子和牛生长激素聚腺苷酸化信号。与含有新霉素抗性基因的质粒共转染后,用G-418筛选稳定转染的细胞系。表达量最高的CHO细胞系每毫克蛋白质含有1400 - 6000单位的α-L-艾杜糖醛酸酶,占细胞总蛋白的0.6 - 2.4%。分泌的α-L-艾杜糖醛酸酶增加了3000至7000倍,每10^7个细胞在24小时内积累约5000单位。其他五种溶酶体糖苷酶的活性和分布未受到显著影响。代谢标记显示,新合成的α-L-艾杜糖醛酸酶有一半被分泌,但由于其在培养基中的不稳定性,通常回收量较少。它经过了翻译后加工,如先前在人成纤维细胞的α-L-艾杜糖醛酸酶中所示。重组α-L-艾杜糖醛酸酶通过利用磷酸甘露糖依赖性机制被胡勒氏成纤维细胞有效内吞(在0.7 nM时摄取达到最大值的一半)并且对异常糖胺聚糖积累具有“校正”作用(在0.7 pM时校正达到最大值的一半)。重组酶被胡勒氏成纤维细胞摄取后的半衰期为5天。在5升微载体培养系统中的生产使得每天能够收集15毫克或更多。(摘要截短为250字)

相似文献

1
Overexpression of the human lysosomal enzyme alpha-L-iduronidase in Chinese hamster ovary cells.人溶酶体酶α-L-艾杜糖醛酸酶在中国仓鼠卵巢细胞中的过表达。
Protein Expr Purif. 1994 Jun;5(3):225-32. doi: 10.1006/prep.1994.1035.
2
Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts.重组α-L-艾杜糖醛酸酶:纯化酶的特性及对I型黏多糖贮积症成纤维细胞的校正
Biochem J. 1994 Nov 15;304 ( Pt 1)(Pt 1):43-9. doi: 10.1042/bj3040043.
3
Purification and characterization of recombinant human alpha-N-acetylglucosaminidase secreted by Chinese hamster ovary cells.中国仓鼠卵巢细胞分泌的重组人α-N-乙酰氨基葡萄糖苷酶的纯化与鉴定
Protein Expr Purif. 2000 Jun;19(1):202-11. doi: 10.1006/prep.2000.1230.
4
Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts.逆转录病毒介导的人α-L-艾杜糖醛酸酶cDNA转移至人造血祖细胞可导致对Hurler成纤维细胞的反式校正。
Gene Ther. 1997 Nov;4(11):1150-9. doi: 10.1038/sj.gt.3300504.
5
alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.黏多糖贮积症 I 型患者中的 α-L-艾杜糖醛酸酶过早终止密码子及潜在的通读现象
J Mol Biol. 2004 Apr 30;338(3):453-62. doi: 10.1016/j.jmb.2004.03.012.
6
Expression and characterization of human recombinant and alpha-N-acetylglucosaminidase.人重组α-N-乙酰氨基葡萄糖苷酶的表达与特性分析
Protein Expr Purif. 2001 Mar;21(2):251-9. doi: 10.1006/prep.2000.1361.
7
Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.接受酶替代疗法的黏多糖贮积症 I 型患者中存在的 α-L-艾杜糖醛酸酶突变的鉴定及分子特征分析
Hum Mutat. 2004 Sep;24(3):199-207. doi: 10.1002/humu.20081.
8
Purification and characterization of recombinant human lysosomal alpha-mannosidase.重组人溶酶体α-甘露糖苷酶的纯化与鉴定
Mol Genet Metab. 2001 May;73(1):18-29. doi: 10.1006/mgme.2001.3173.
9
Apparent allelism of the Hurler, Scheie, and Hurler/Scheie syndromes.胡勒氏综合征、谢伊氏综合征和胡勒/谢伊氏综合征的明显等位基因现象。
Am J Med Genet. 1984 Jul;18(3):547-56. doi: 10.1002/ajmg.1320180324.
10
Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice.新生期给予表达α-L-艾杜糖醛酸酶的逆转录病毒载体对黏多糖贮积症I型小鼠脑及其他器官溶酶体贮积的影响。
Mol Genet Metab. 2007 Feb;90(2):181-92. doi: 10.1016/j.ymgme.2006.08.001. Epub 2006 Sep 18.

引用本文的文献

1
A Review: Development of a Synthetic Lactoferrin Biological System.综述:合成乳铁蛋白生物系统的发展
Biodes Res. 2024 Aug 6;6:0040. doi: 10.34133/bdr.0040. eCollection 2024.
2
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies.糖基化影响多种蛋白、基因和细胞治疗的疗效和安全性。
Biotechnol Adv. 2023 Oct;67:108206. doi: 10.1016/j.biotechadv.2023.108206. Epub 2023 Jun 22.
3
A Historical Review of Brain Drug Delivery.脑药物递送的历史回顾
Pharmaceutics. 2022 Jun 16;14(6):1283. doi: 10.3390/pharmaceutics14061283.
4
Surrogate Cerebrospinal Fluid Biomarkers for Assessing the Efficacy of Gene Therapy in Hurler Syndrome.用于评估黏多糖贮积症I型基因治疗疗效的替代脑脊液生物标志物
Front Neurol. 2021 May 13;12:640547. doi: 10.3389/fneur.2021.640547. eCollection 2021.
5
Galactosialidosis: preclinical enzyme replacement therapy in a mouse model of the disease, a proof of concept.半乳糖唾液酸贮积症:疾病小鼠模型中的临床前酶替代疗法,一项概念验证研究。
Mol Ther Methods Clin Dev. 2020 Nov 20;20:191-203. doi: 10.1016/j.omtm.2020.11.012. eCollection 2021 Mar 12.
6
Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α--Acetylglucosamine-6-Sulfatase in Neonatal Mice.用重组人α-乙酰氨基葡萄糖-6-硫酸酯酶治疗新生期小鼠黏多糖贮积症 III 型。
Mol Pharm. 2021 Jan 4;18(1):214-227. doi: 10.1021/acs.molpharmaceut.0c00831. Epub 2020 Dec 15.
7
Production and Purification of Therapeutic Enzymes.治疗酶的生产和纯化。
Adv Exp Med Biol. 2019;1148:1-24. doi: 10.1007/978-981-13-7709-9_1.
8
Brassica rapa hairy root based expression system leads to the production of highly homogenous and reproducible profiles of recombinant human alpha-L-iduronidase.芸薹根毛状根表达系统导致重组人α-L-艾杜糖苷酸酶产生高度均一和可重现的谱。
Plant Biotechnol J. 2019 Feb;17(2):505-516. doi: 10.1111/pbi.12994. Epub 2018 Aug 30.
9
P-Tau and Subunit c Mitochondrial ATP Synthase Accumulation in the Central Nervous System of a Woman with Hurler-Scheie Syndrome Treated with Enzyme Replacement Therapy for 12 Years.在接受酶替代疗法治疗12年的一名Hurler-Scheie综合征女性患者的中枢神经系统中P- tau蛋白和线粒体ATP合酶亚基c的积累
JIMD Rep. 2018;41:101-107. doi: 10.1007/8904_2018_106. Epub 2018 Apr 29.
10
Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.溶酶体酶替代疗法:历史发展、临床结果和未来展望。
Adv Drug Deliv Rev. 2017 Sep 1;118:109-134. doi: 10.1016/j.addr.2017.05.004. Epub 2017 May 11.